WHO ICTRP trial
A comparative study of the therapeutic effect of topical finasteride with oral…
IRCT20220901055844N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20220901055844N1 |
|---|---|
| Public title | A comparative study of the therapeutic effect of topical finasteride with oral finasteride in patients with androgenetic alopecia . |
| Scientific title | A comparative study of the therapeutic effect of topical finasteride with oral finasteride in patients with androgenetic alopecia . |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Androgenic alopecia. Androgenic alopecia |
| Interventions | Intervention group: In group A, finasteride drug in oral form will be used. In this group, finasteride 1 mg tablets will be prescribed daily for male patients and 5 mg tablets manufactured by Ati Pharmed pharmaceutical company for female… |
| Registration date | Dec 19, 2023 |
| Target size | 28 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: